The shutdown order on three companies involved in the codeine documentary by BBC Africa Eye has been lifted and the normal company operations can resume.
According to the Director General of  National Agency for Food and Drug Administration and Control (NAFDAC), Prof Mojisola Christianah Adeyeye, the companies have however  been given the following sanctions:
*All production of codeine syrup should be stopped immediately until further notice. Therefore, the HOLD placed on the active pharmaceutical ingredient and the already made codeine syrups stands. NAFDAC will monitor the compliance.
*All codeine products are to be recalled and the process verified through audit trail verified by NAFDAC
The DG added that as earlier directed, an embargo has been placed on new applications for permit or renewals for the importation of codeine as an active pharmaceutical ingredient for cough preparations.
The companies have been charged with administrative fees that are commensurate with the respective violations.
NAFDAC will hold a stakeholders meeting on the codeine crisis soon to develop a road map for the supply chain distribution and the future of codeine syrup manufacturing, in line with the Minister of Health pronouncements in his press release on the codeine crisis.
The lifting followed a meeting convened by National Agency for Food and Drug Administration and Control, with its DG and representatives having had a high-powered meeting with the executives of the companies that were implicated in the codeine syrup distribution on Thursday, May 10, 2018 in Lagos.
NAFDAC had separate meetings with the companies – Peace Standard Pharmaceutical Limited and Bioraj Pharmaceutical Limited in Ilorin, Kwara State, and Emzor Pharmaceuticals Ind. Ltd, Lagos – to further the investigation into the codeine manufacture and distribution with possibility of lifting the shutdown of the companies.
The Director General, Prof Adeyeye gave the directive for the meetings to be held with the companies.
The following NAFDAC directorates – Investigation and Enforcement (I&E), Drug Evaluation Research (DER) and Narcotics and Controlled Substances (NCS) led the meeting.
The findings of the investigations, and violations committed by the companies (based on the first inspections conducted on May 3, and BBC documentary), are stated below:
*Peace Standard Pharmaceutical Limited: Mr. Samuel Akinlaja, the Managing Director led his team to the meeting.  The company was cited for poor distribution practice and misplaced role play of staff.
*NAFDAC made the following observations.
The Superintendent Pharmacist assumed a function that was not part of his Job schedule by attending to an intending customer.
Good Distribution Practice (GDP) was not strictly implemented by the company.
The company has been warned to ensure strict compliance with all written standard operating procedures (SOP).
From the outcome of the inspection, the company’s documentation process was adequate as the records from the raw materials store, in process and finished products were properly reconciled.
Bioraj Pharmaceutical Limited: Mr. Rahamon J. Bioku, the Managing Director led his team at the meeting with NAFDAC.  Based on the documentary and discussions, the company violated GDP by not monitoring the accredited distributors, a worker colluded with a sacked staff to illegally distribute codeine syrup that was allegedly stolen from the company. The company was also cited for bad storage practice or poor good manufacturing practice